| ASYLX | DIAYX | ASYLX / DIAYX | |
| Total Expense Ratio | 1.65 | 1.28 | 129% |
| Annual Report Gross Expense Ratio | 1.72 | 1.28 | 134% |
| Fund Existence | 13 years | 14 years | - |
| Gain YTD | 4.851 | -3.653 | -133% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.49B | 2.22B | 67% |
| Annual Yield % from dividends | 0.88 | 1.72 | 51% |
| Returns for 1 year | 1.38 | 8.43 | 16% |
| Returns for 3 years | 21.92 | 27.64 | 79% |
| Returns for 5 years | 2.85 | 7.50 | 38% |
| Returns for 10 years | 35.91 | 40.75 | 88% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PWB | 163.21 | 0.82 | +0.50% |
| Invesco Large Cap Growth ETF | |||
| GRNI | 21.45 | 0.07 | +0.30% |
| Fundstrat Granny Shots Us Large Cap & Income ETF | |||
| KNOV | 31.16 | 0.07 | +0.24% |
| Innovator U.S. Small Cp Pwr Buf ETF -Nov | |||
| FLUD | 24.95 | -0.01 | -0.04% |
| Franklin Ultra Short Bond ETF | |||
| BIB | 76.69 | -4.77 | -5.85% |
| ProShares Ultra Nasdaq Biotechnology | |||